| 000 | 01372 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250518040001.0 | ||
| 264 | 0 | _c20200323 | |
| 008 | 202003s 0 0 eng d | ||
| 022 | _a1550-7416 | ||
| 024 | 7 |
_a10.1208/s12248-019-0336-8 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLagassé, H A Daniel | |
| 245 | 0 | 0 |
_aFc-Fusion Drugs Have FcγR/C1q Binding and Signaling Properties That May Affect Their Immunogenicity. _h[electronic resource] |
| 260 |
_bThe AAPS journal _c05 2019 |
||
| 300 |
_a62 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Intramural | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _ximmunology |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aComplement C1q _ximmunology |
| 650 | 0 | 4 |
_aDrug Hypersensitivity _ximmunology |
| 650 | 0 | 4 |
_aHistocompatibility Antigens Class I _ximmunology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunoglobulin Fc Fragments _ximmunology |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aProtein Binding |
| 650 | 0 | 4 |
_aReceptors, Fc _ximmunology |
| 650 | 0 | 4 |
_aReceptors, IgG _xmetabolism |
| 650 | 0 | 4 | _aSignal Transduction |
| 700 | 1 | _aHengel, Hartmut | |
| 700 | 1 | _aGolding, Basil | |
| 700 | 1 | _aSauna, Zuben E | |
| 773 | 0 |
_tThe AAPS journal _gvol. 21 _gno. 4 _gp. 62 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1208/s12248-019-0336-8 _zAvailable from publisher's website |
| 999 |
_c29664305 _d29664305 |
||